Why are you looking at Aligos Therapeutics?
Email me when a Aligos Therapeutics recompete window opens.
Capability
Service linesRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Work mix: 100% prime · 0% sub · primary NAICS 541715 / PSC AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Where they win
Sole agencyRecompete exposure: Moderate · 1 in 24mo
Aligos Therapeutics has an estimated $11.3M in contracts returning to market over the next 24 months.
Agency buyer map
1 buyersRecompete exposure
ModerateAligos Therapeutics has an estimated $11.3M in contracts returning to market over the next 24 months. 1 within 6 months ($11.3M).
“With competitive federal procurements, winning starts with strategically understanding the customer environment to the left of SAM.gov. This is what SCOUT does - a deeper and more precise understanding of what the…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Aligos Therapeutics hold?
Aligos Therapeutics (UEI ED19ABDRLV29) shows $11.3M across 1 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Aligos Therapeutics have?
Aligos Therapeutics shows $11.3M across 1 award actions. SCOUT tracks 1 incumbent recompetes ($11.3M) returning to market in the next 24 months.
Which agencies does Aligos Therapeutics work with?
Aligos Therapeutics’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (100%).
What is the UEI for Aligos Therapeutics?
The Unique Entity ID (UEI) for Aligos Therapeutics is ED19ABDRLV29.
Does Aligos Therapeutics have contracts coming up for recompete?
Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (Moderate exposure). Open the recompete section on this page for PIID-level timing.
Seen enough? Run one full capture cycle on Aligos Therapeutics — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.